4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
- Product Name
- 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
- CAS No.
- 566169-98-0
- Chemical Name
- 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
- Synonyms
- 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine;Benzenamine, 4-(6-bromo-2-benzothiazolyl)-N-methyl-
- CBNumber
- CB64797016
- Molecular Formula
- C14H11BrN2S
- Formula Weight
- 319.22
- MOL File
- 566169-98-0.mol
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine Property
- storage temp.
- Store at -20°C
- solubility
- Soluble in DMSO
- form
- Solid
- color
- Light yellow to yellow
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P261Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
N-Bromosuccinimide Price
- Product number
- B997398
- Product name
- 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine
- Packaging
- 2.5mg
- Price
- $90
- Updated
- 2021/12/16
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine Chemical Properties,Usage,Production
Uses
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine, is a potent amyloid imaging agent which binds to Amyloid-β (1-40) with a KD of 1.7 nM.
in vivo
Alzhermer's Disease (AD) is a neurodegenerative illness characterized by memory loss and other cognitive deficits. The ability to quantify amyloid load before treatment is critical to the efficient development of this class of drugs[2]. Brain entry in control mice and baboons is high for 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine. Staining of AD frontal cortex tissue sections with 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine indicates the selective binding of the compound to amyloid plaques and cerebrovascular amyloid. The encouraging properties of the compound support the choice of this derivative for further evaluation in human subject studies of brain Amyloid-βdeposition. The brain radioactivity concentrations (%ID-kg/g) of 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine is remarkably similar in mice and baboons (0.21 vs 0.27). The rate of clearance of radioactivity is considerably slower from baboon brain than from mouse brain, although the rank order of clearance rate is similar in mice and baboons. The tissue staining findings utilizing nonradiolabeled, fluorescent 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine are similar to those reported for BTA-1. Both amyloid plaques and cerebrovascular amyloid are stained by 4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine in a manner similar to serial sections stained with an antibody to Amyloid-β, and relatively little tissue background staining is observed[1].
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine Preparation Products And Raw materials
Raw materials
Preparation Products
4-(6-Bromo-2-benzothiazolyl)-N-methylbenzenamine Suppliers
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32435
- Advantage
- 58
- Tel
- 13348960310
- 3003867561@qq.com
- Country
- China
- ProdList
- 10503
- Advantage
- 58
- Tel
- 15002134094
- marketing@targetmol.cn
- Country
- China
- ProdList
- 29423
- Advantage
- 58
- Tel
- 51288865780
- sales@biosynth.com
- Country
- China
- ProdList
- 6051
- Advantage
- 58
- Tel
- 400-025-6535
- sales@adooq.cn
- Country
- China
- ProdList
- 6215
- Advantage
- 58